B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HMGB1

MOLECULAR TARGET

high mobility group box 1

UniProt: P09429NCBI Gene: 31464 compounds

HMGB1 (high mobility group box 1) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HMGB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1methotrexate6.00404
2glycyrrhizin3.9551
3Methotrexate1.102
4Salicylic Acid1.102

About HMGB1 as a Drug Target

HMGB1 (high mobility group box 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented HMGB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HMGB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.